Molina Healthcare’s (MOH) “Hold” Rating Reiterated at Raymond James Financial

Molina Healthcare (NYSE:MOH)‘s stock had its “hold” rating reiterated by analysts at Raymond James Financial in a research note issued on Friday.

MOH has been the subject of several other reports. Jefferies Group increased their price objective on Molina Healthcare from $64.00 to $74.00 and gave the stock a “hold” rating in a research note on Friday, November 3rd. Zacks Investment Research lowered Molina Healthcare from a “hold” rating to a “sell” rating in a research note on Tuesday, October 3rd. Wolfe Research upgraded Molina Healthcare from a “market perform” rating to an “outperform” rating in a research note on Monday, October 23rd. Morgan Stanley raised their target price on Molina Healthcare from $68.00 to $89.00 and gave the company an “overweight” rating in a research note on Friday, November 3rd. Finally, ValuEngine lowered Molina Healthcare from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $64.30.

Molina Healthcare (NYSE MOH) traded up $0.96 during trading hours on Friday, reaching $75.42. The company had a trading volume of 447,696 shares, compared to its average volume of 1,259,724. Molina Healthcare has a 12-month low of $42.56 and a 12-month high of $80.74. The firm has a market capitalization of $4,290.00, a P/E ratio of 23.07 and a beta of 0.97. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 1.06.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Thursday, November 2nd. The company reported ($1.62) EPS for the quarter, missing analysts’ consensus estimates of $0.23 by ($1.85). The firm had revenue of $5.03 billion during the quarter, compared to analyst estimates of $4.95 billion. Molina Healthcare had a positive return on equity of 17.76% and a negative net margin of 1.76%. The company’s quarterly revenue was up 10.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.85 EPS. equities analysts predict that Molina Healthcare will post -3.88 earnings per share for the current year.

In related news, Director Garrey Carruthers sold 1,300 shares of the business’s stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $75.66, for a total value of $98,358.00. Following the completion of the sale, the director now directly owns 7,016 shares in the company, valued at approximately $530,830.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director J Mario Md Molina sold 15,000 shares of the business’s stock in a transaction on Monday, December 4th. The shares were sold at an average price of $78.52, for a total value of $1,177,800.00. The disclosure for this sale can be found here. Insiders have sold a total of 407,523 shares of company stock worth $28,505,592 in the last ninety days. Insiders own 6.20% of the company’s stock.

Several institutional investors have recently bought and sold shares of MOH. LS Investment Advisors LLC raised its holdings in shares of Molina Healthcare by 40.9% during the 2nd quarter. LS Investment Advisors LLC now owns 1,829 shares of the company’s stock worth $127,000 after buying an additional 531 shares in the last quarter. Nisa Investment Advisors LLC raised its holdings in shares of Molina Healthcare by 2.7% during the 2nd quarter. Nisa Investment Advisors LLC now owns 5,660 shares of the company’s stock worth $392,000 after buying an additional 150 shares in the last quarter. Aperio Group LLC increased its holdings in Molina Healthcare by 28.0% in the 2nd quarter. Aperio Group LLC now owns 19,602 shares of the company’s stock worth $1,356,000 after purchasing an additional 4,282 shares in the last quarter. Russell Investments Group Ltd. increased its holdings in Molina Healthcare by 165.4% in the 2nd quarter. Russell Investments Group Ltd. now owns 144,211 shares of the company’s stock worth $9,976,000 after purchasing an additional 89,870 shares in the last quarter. Finally, Texas Permanent School Fund increased its holdings in Molina Healthcare by 1.3% in the 2nd quarter. Texas Permanent School Fund now owns 31,214 shares of the company’s stock worth $2,159,000 after purchasing an additional 398 shares in the last quarter. 96.23% of the stock is owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This report was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another publication, it was stolen and republished in violation of United States & international copyright & trademark laws. The original version of this report can be viewed at https://www.dispatchtribunal.com/2017/12/08/molina-healthcares-moh-hold-rating-reiterated-at-raymond-james-financial.html.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply